Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Injection – 0.5-mL suspension Frequency: intramuscular injection at the following schedule: 0, 2 months, 6 months |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Cervical, vulvar, vaginal, and anal cancer; genital warts; and precancerous or dysplastic lesions Age: 9 through 14 years |
Dose: Intramuscular injection – 0.5 mL Frequency: 2-dose (0, 6–12 months) schedule Note: intramuscular |
|
Indication: Cervical, vulvar, vaginal, and anal cancer; genital warts; and precancerous or dysplastic lesions Age: 9 through 14 years |
Dose: Intramuscular injection – 0.5 mL Frequency: 3-dose (0, 2, 6 months) schedule Note: intramuscular |
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.